Page last updated: 2024-10-24

chlorambucil and Demyelinating Diseases

chlorambucil has been researched along with Demyelinating Diseases in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drake, WM1
Monson, JP1
Trainer, PJ1
Sharief, M1
Dick, JP1
Kelsey, SM1
Ernerudh, JH1
Vrethem, M1
Andersen, O1
Lindberg, C1
Berlin, G1

Other Studies

2 other studies available for chlorambucil and Demyelinating Diseases

ArticleYear
Acute polyneuropathy with chronic lymphocytic leukaemia and paraproteinaemia: response to chlorambucil and prednisolone.
    Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 64, Issue:4

    Topics: Acute Disease; Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Demy

1998
Immunochemical and clinical effects of immunosuppressive treatment in monoclonal IgM neuropathy.
    Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:10

    Topics: Adult; Aged; Blood Proteins; Chlorambucil; Demyelinating Diseases; Drug Therapy, Combination; Female

1992